MedPath

Ferumoxytol

Generic Name
Ferumoxytol
Brand Names
Feraheme
Drug Type
Small Molecule
Chemical Formula
Fe3O4
CAS Number
722492-56-0
Unique Ingredient Identifier
G6N3J05W84

Overview

Ferumoxytol is an intravenously administered iron preparation indicated in the EU and the US for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) . It is comprised of superparamagnetic iron oxide nanoparticles which are coated by a semi-synthetic carbohydrate shell in an isotonic, neutral pH solution that may be administered at relatively high dose by rapid intravenous injection .

Background

Ferumoxytol is an intravenously administered iron preparation indicated in the EU and the US for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) . It is comprised of superparamagnetic iron oxide nanoparticles which are coated by a semi-synthetic carbohydrate shell in an isotonic, neutral pH solution that may be administered at relatively high dose by rapid intravenous injection .

Indication

This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron or have experienced an unsatisfactory response to oral iron or who have chronic kidney disease (CKD) .

Associated Conditions

  • Iron Deficiency Anemia (IDA)

FDA Approved Products

Feraheme
Manufacturer:AMAG Pharmaceuticals, Inc.
Route:INTRAVENOUS
Strength:510 mg in 17 mL
Approved: 2022/06/13
NDC:59338-775
Ferumoxytol
Manufacturer:Sandoz Inc
Route:INTRAVENOUS
Strength:510 mg in 17 mL
Approved: 2020/09/22
NDC:0781-3154

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath